These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Structure and function of beta3-adrenergic receptors. Skeberdis VA Medicina (Kaunas); 2004; 40(5):407-13. PubMed ID: 15170407 [TBL] [Abstract][Full Text] [Related]
5. Potent benzimidazolone based human beta(3)-adrenergic receptor agonists. Finley DR; Bell MG; Borel AG; Bloomquist WE; Cohen ML; Heiman ML; Kriauciunas A; Matthews DP; Miles T; Neel DA; Rito CJ; Sall DJ; Shuker AJ; Stephens TW; Tinsley FC; Winter MA; Jesudason CD Bioorg Med Chem Lett; 2006 Nov; 16(21):5691-4. PubMed ID: 16931005 [TBL] [Abstract][Full Text] [Related]
7. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798 [TBL] [Abstract][Full Text] [Related]
8. Potent and selective, sulfamide-based human beta 3-adrenergic receptor agonists. Dow RL; Paight ES; Schneider SR; Hadcock JR; Hargrove DM; Martin KA; Maurer TS; Nardone NA; Tess DA; DaSilva-Jardine P Bioorg Med Chem Lett; 2004 Jun; 14(12):3235-40. PubMed ID: 15149682 [TBL] [Abstract][Full Text] [Related]
9. The negative inotropic action of catecholamines: role of beta3-adrenoceptors. Gauthier C; Leblais V; Moniotte S; Langin D; Balligand JL Can J Physiol Pharmacol; 2000 Sep; 78(9):681-90. PubMed ID: 11007530 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of memory consolidation in chicks by beta(3)-adrenoceptor agonists. Gibbs ME; Summers RJ Eur J Pharmacol; 2001 Feb; 413(2-3):235-40. PubMed ID: 11226398 [TBL] [Abstract][Full Text] [Related]
11. Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist. Parmee ER; Ok HO; Candelore MR; Tota L; Deng L; Strader CD; Wyvratt MJ; Fisher MH; Weber AE Bioorg Med Chem Lett; 1998 May; 8(9):1107-12. PubMed ID: 9871717 [TBL] [Abstract][Full Text] [Related]
12. Studies on the expression and function of beta-3-adrenoceptors in the colon of rats with acetic acid-induced colitis. Khan I; Hussein SM; Oriowo M Pharmacology; 2002 Feb; 64(2):98-105. PubMed ID: 11803250 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres. Uehling DE; Donaldson KH; Deaton DN; Hyman CE; Sugg EE; Barrett DG; Hughes RG; Reitter B; Adkison KK; Lancaster ME; Lee F; Hart R; Paulik MA; Sherman BW; True T; Cowan C J Med Chem; 2002 Jan; 45(3):567-83. PubMed ID: 11806709 [TBL] [Abstract][Full Text] [Related]
14. [beta 3-adrenergic receptor agonists as anti-obese and anti-diabetic drugs]. Sakura H; Togashi M; Iwamoto Y Nihon Rinsho; 2002 Jan; 60(1):123-9. PubMed ID: 11808322 [TBL] [Abstract][Full Text] [Related]
15. Beta 3-adrenoceptors in the cardiovascular system. Gauthier C; Sèze-Goismier C; Rozec B Clin Hemorheol Microcirc; 2007; 37(1-2):193-204. PubMed ID: 17641409 [TBL] [Abstract][Full Text] [Related]
16. Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptor. Weber AE; Mathvink RJ; Perkins L; Hutchins JE; Candelore MR; Tota L; Strader CD; Wyvratt MJ; Fisher MH Bioorg Med Chem Lett; 1998 May; 8(9):1101-6. PubMed ID: 9871716 [TBL] [Abstract][Full Text] [Related]
17. Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformations. Washburn WN; Harper TW; Wu G; Godfrey JD; McCann P; Girotra R; Shao C; Zhang H; Gavai A; Mikkilineni A; Dejneka T; Ahmed S; Caringal Y; Hangeland J; Zhang M; Cheng PT; Russell AD; Skwish S; Slusarchyk DA; Allen GT; Frohlich BH; Abboa-Offei BE; Cap M; Waldron TL; George RJ; Tesfamariam B; Dickinson KE; Seymour AA; Sher PM Bioorg Med Chem Lett; 2007 Aug; 17(15):4290-6. PubMed ID: 17533126 [TBL] [Abstract][Full Text] [Related]
18. Decreased core temperature and increased beta(3)-adrenergic sensitivity in diabetes-prone BB rats. Akesson L; Hawkins T; Jensen R; Fuller JM; Breslow NE; Lernmark A Diabetes Technol Ther; 2007 Aug; 9(4):354-62. PubMed ID: 17705691 [TBL] [Abstract][Full Text] [Related]
19. Effects of two beta3-agonists, CGP 12177A and BRL 37344, on coronary flow and contractility in isolated guinea pig heart. Kozlovski VI; Chlopicki S; Gryglewski RJ J Cardiovasc Pharmacol; 2003 May; 41(5):706-13. PubMed ID: 12717100 [TBL] [Abstract][Full Text] [Related]
20. Genotyping and drug response: use of single nucleotide polymorphisms (SNPs) versus haplotypes to predict albuterol efficacy. Schubbert S AAPS PharmSci; 2001; 3(3):1. PubMed ID: 11783424 [No Abstract] [Full Text] [Related] [Next] [New Search]